A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix

International Journal of Clinical Oncology

Volumn 9, Issue 1, 2004, Pages 59-63

  Tabata, Tsutomu ^a   Nishiura, Keisuke ^a   Yanoh, Kenji ^a   Okugawa, Toshiharu ^a   Obata, Hidenori ^a   Tanaka, Keisuke ^a   Toyoda, Nagayasu ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; Cervical cancer; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; ETOPOSIDE; MITOMYCIN C;

ADENOCARCINOMA; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FEMALE; HEART DISEASE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INFECTION; LEUKOPENIA; NEUTROPENIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PILOT PROJECTS; RADIOTHERAPY, ADJUVANT; STATISTICS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

EID: 1842734061     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-003-0363-3     Document Type: Article

References (19)

1. Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcioma of the cervix. Obstet Gynecol 77:912-917
2. Eifel PJ, Burke TW, Morris M, et al. (1995) Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59:38-44
3. Chen RJ, Chang DY, Yen ML, et al. (1998) Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 69:157-164
4. Drescher CW, Hopkins MP, Roberts JA (1989) Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix. Gynecol Oncol 33:340-343
5. Serur E, Matthews RP, Gates J, et al. (1997) Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma. Gynecol Oncol 65:348-356
6. Sardi J, Giaroli A, Sananes C, et al. (1997) Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 67:61-69
7. Creasman WT (1995) New gynecologic cancer staging. Gynecol Oncol 58:157-158
8. World Health Organization (1979) WHO/UICC handbook for reporting results of cancer treatment. WHO Offset Publication No. 48. WHO, Geneva, pp 14-27
9. Iwasaka T, Fukuda K, Hara K, et al. (1998) Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. Gynecol Oncol 70:236-240
10. Lissoni A, Gabriele A, Gorga G, et al. (1997) Cisplatin-, epirubicin- and paclitaxel-containing chemotheray in uterine adenocarcinoma. Ann Oncol 8:969-972
11. Aoki Y, Sato T, Watanabe M, et al. (2001) Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma. Gynecol Oncol 81:496-499
12. Zanetta G, Lissoni A, Gabriele A, et al. (1997) Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecol Oncol 64:431-435
13. Benedetti-Panici P, Greggi S, Scambia G, et al. (1996) Locally advanced cervical adenocarcinoma: is there a place for chemosurgical treatment? Gynecol Oncol 61:44-49
14. Collins JM (1984) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498-504
15. Lutz RJ, Epstein AH, Cook JA, et al. (1995) An in vitro flow model to study streaming during pelvic intraarterial drug infusions. Gynecol Oncol 59:288-296
16. Kin D, Moon H, Kim K, et al. (1989) Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer Stages IB and II with bulky tumor. Gynecol Oncol 33:225-230
17. Shingleton HM, Gore H, Bradley DH, et al. (1981) Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features. Am J Obstet Gynecol 139:799-814
18. Dottino PR, Plaxe SC, Beddoe AM, et al. (1991) Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 40:7-11
19. Shimizu Y, Akiyama F, Umezawa S, et al. (1998) Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma. J Clin Oncol 16:1869-1878